Tofajak 5mg Bottle Of 60 Tablets

Specifications

Storage Tips

Store below 30°C

Dosage Type

Tablet

Salt composition

Tofacitinib (5.0 mg)

Packaging

Bottle

Safety Advice

Pregnancy: Caution- Limited information is available on the use of Tofajak 5 mg tablet in pregnant women. Use in pregnancy is not recommended. Breast feeding: Unsafe- Breastfeeding is not recommended during treatment and for at least 18 hours after the last dose of Tofajak 5. Driving: Safe If Prescribed- Tofajak 5 has no or negligible influence on the ability to drive and use machines. Alcohol: Caution- No information is available on the interactions of Tofajak 5 mg tablet and alcohol.

Side Effects

Headache, Upper Respiratory Tract Infection, Diarrhea, Nasopharyngitis (Inflammation Of The Throat And Nasal Passages)

Interaction with Drugs

Drug: Herpes Zoster / Shingles Vaccine (Recombinant, Adjuvanted) (Injection Route) Description: Do not use Tofacitinib with Herpes Zoster / Shingles Vaccine (Recombinant, Adjuvanted). Concurrent use may increase the risk of infections. Drug: Carbamazepine (Oral Route) Description: Do not consume Tofacitinib with Carbamazepine. Carbamazepine may reduce blood levels of Tofacitinib. Concurrent use may result in loss of efficacy of Tofacitinib. Drug: Fosphenytoin (Injection Route) Description: Do not consume Tofacitinib with Fosphenytoin. Fosphenytoin may reduce blood levels of Tofacitinib. Concurrent use may result in loss of efficacy of Tofacitinib. Drug: Bosentan (Oral Route) Description: Do not consume Tofacitinib with Bosentan. Bosentan may reduce blood levels of Tofacitinib. Drug: Cholera Vaccine (Inactivated) (Oral Route) Description: Do not use Tofacitinib with Cholera Vaccine (Inactivated). Concurrent use may increase the risk of infections.

Uses

Rheumatoid Arthritis Active Psoriatic Arthritis